Join the Birth Control group to help and get support from people like you.
Birth Control News (Page 7)
Related terms: Fertility Control, Anticonception
FDA Medwatch Alert: Birth Control Pills Containing Drospirenone: Label Change-Products may be associated with a higher risk for blood clots
ISSUE: FDA has completed its review of recent observational (epidemiologic) studies regarding the risk of blood clots in women taking drospirenone-containing birth control pills.Based on this review,...
FDA Medwatch Alert: Norgestimate and Ethinyl Estradiol Tablets: Recall - Packaging Error, Potential for Incorrect Dosing Regimen
ISSUE: Glenmark Generics Inc. issued a nationwide, consumer-level recall of seven (7) lots of Norgestimate and Ethinyl Estradiol Tablets USP (0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg),...
FDA Medwatch Alert: Birth Control Pills Containing Drospirenone: Possible Increased Risk of Blood Clots
[UPDATED 09/26/2011] FDA has not yet reached a conclusion, but remains concerned, about the potential increased risk of blood clots with the use of drospirenone-containing birth control pills. FDA...
FDA Medwatch Alert: Qualitest Pharmaceuticals Oral Contraceptives: Recall - Packaging Error
includes Cyclafem 7/7/7, Cyclafem 1/35, Emoquette, Gildess FE 1.5/30, Gildess FE 1/20, Orsythia, Previfem, Tri-Previfem ISSUE: Qualitest Pharmaceuticals issued a nationwide, retail-level recall of...
FDA Medwatch Alert: Birth Control Pills Containing Drospirenone: Possible Increased Risk of Blood Clots
ISSUE: FDA is aware of two newly published studies that evaluated the risk of venous thromboembolism (VTE) in women who use birth control pills that contain drospirenone. The two recently published...
FDA Approves Safyral - Oral Contraceptive That Also Raises Folate Levels
WAYNE, N.J., Dec. 16, 2010 /PRNewswire/ – Bayer HealthCare Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved a new oral contraceptive (OC), Safyral...
Warner Chilcott Announces FDA Approval of New Oral Contraceptive Lo Loestrin Fe
ARDEE, Ireland, Oct. 22 /PRNewswire-FirstCall/ – Warner Chilcott plc today announced that the United States Food and Drug Administration (FDA) has approved Lo Loestrin Fe (norethindrone acetate and...
FDA Approves Beyaz - Combination Contraceptive Containing a Folate
ROCKVIILE, Md., Sept. 24, 2010--The U.S. Food and Drug Administration today approved Beyaz tablets, an estrogen/progestin combined oral contraceptive that also contains a folate (levomefolate calcium...
FDA Approves Natazia - New Combination Product Oral Contraceptive
ROCKVILLE, Md., May 6, 2010--The U.S. Food and Drug Administration today approved Natazia, a combination hormonal tablet for use as an oral contraceptive. Natazia contains two female hormones, an...
FDA Medwatch Alert: Ortho Evra Contraceptive Transdermal Patch
[Posted 01/19/2008] FDA modified the prescribing information for the Ortho Evra Contraceptive Transdermal (Skin) Patch to include the results of a new epidemiology study that found that users of the...
FDA Medwatch Alert: Ortho Evra (norelgestromin/ethinyl estradiol)
[Posted 09/20/2006] Ortho-McNeil and FDA notified healthcare professionals and patients about revisions to the prescribing information to inform them of the results of two separate epidemiology...
FDA Medwatch Alert: Counterfeit contraceptive patches
FDA and Johnson and Johnson Co. of Raritan, NJ are warning the public about an overseas internet site selling counterfeit contraceptive patches that contain no active ingredients.The counterfeit...
FDA Medwatch Alert: Nonoxynol 9 (N9) OTC Contraceptive Products
[Posted 12/18/2007] FDA issued a final rule that requires that manufacturers of over-the-counter stand-alone vaginal contraceptive and spermicidal products containing the chemical ingredient...
Further information
Related condition support groups
Emergency Contraception, Postcoital Contraception
Related drug support groups
Depo-Provera, Nexplanon, Provera, NuvaRing, Mirena, Implanon, levonorgestrel, Sprintec, Loestrin 24 Fe, Yasmin, Lo Loestrin Fe, medroxyprogesterone, Kyleena